Literature DB >> 15111452

Drug therapy for Alzheimer's disease.

Shane Kavanagh, Patricia Kabathova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15111452      PMCID： PMC395792          DOI： 10.1503/cmaj.1031912

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease.

Authors:  D Wilkinson; J Murray
Journal:  Int J Geriatr Psychiatry       Date:  2001-09       Impact factor: 3.485

2.  Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.

Authors:  G K Wilcock; S Lilienfeld; E Gaens
Journal:  BMJ       Date:  2000-12-09

3.  Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

Authors:  M A Raskind; E R Peskind; T Wessel; W Yuan
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

4.  A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

Authors:  P N Tariot; P R Solomon; J C Morris; P Kershaw; S Lilienfeld; C Ding
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

Review 5.  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Authors:  Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

6.  Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Authors:  K Rockwood; J Mintzer; L Truyen; T Wessel; D Wilkinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

7.  A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.

Authors:  Gordon Wilcock; Ian Howe; Hilary Coles; Sean Lilienfeld; Luc Truyen; Young Zhu; Roger Bullock; Paul Kershaw
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.